OncoSec Receives Notice of Allowance from US Patent and Trademark Office for Patent Application with Claims Covering Cytokine-Based Intratumoral Immunotherapies – PRNewswire

OncoSec Receives Notice of Allowance from US Patent and Trademark Office for Patent Application with Claims Covering Cytokine-Based Intratumoral Immunotherapies  PRNewswire

SAN DIEGO and PENNINGTON, N.J., July 29, 2019 /PRNewswire/ — OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing …